Joint working with NHS
Benefits
The Guidance notes on Joint Working state that the following are potential benefits from NHS organisations Joint Working with the Pharmaceutical Industry -
For patients
- Care closer to home
- Fewer hospital admissions
- More equitable and consistent care and access to care
- Better information about conditions and treatment options
- Clearer and improved care pathways
- Better experience of the healthcare system
For the NHS
- Higher quality, more consistent care achieved more rapidly
- Services configured around patients' needs
- Better health outcomes
- Better use of resources, greater value for money, lower costs
- More people treated appropriately (e.g. in line with national guidelines)
- Lower costs of hospital admissions
- Support towards achievement of performance targets
- More creative approaches to problems
- Better cross-sectional working
- Better skilled personnel
For the pharmaceutical company
- More and/or better use of medicines, including the company's medicine(s)
- Better understanding of customers' and patients' needs
- Improved reputation
- Faster NHS implementation of policy which may be relevant to the company's business
Examples of Joint Working
(as illustrated within the guidance notes from the ABPI for Joint Working)
- staff training
- staff and/or patient education
- economic analysis
- nurse services
- facilitation of pathway redesign
- support for guideline implementation
- funding of project staff requirements (e.g. provision of administrative, clinical, analytical health economic and/or
management resources by either party)
- secondments
- audit
